🧠 “Chemkart IPO: Protein Powder, Plant Extracts, and a ₹300 Cr Valuation Flex?”
Date of Publishing -
Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.
At a Glance
Chemkart India Ltd, a B2B distributor of amino acids, vitamins, and sports supplements, is launching a ₹80.08 Cr IPO — a mix of ₹64.48 Cr fresh issue and ₹15.60 Cr OFS. With 67% PAT growth and 59% ROE, the numbers look shredded like a gym bro on creatine. But is the ₹248/share price tag worth it — or are we just overpaying for glorified packaging of L-leucine?
1. 🎯 Introduction with Hook
The IPO market has gone from steel, sugar, and software… to whey protein and plant extracts. 💪🌿
Enter Chemkart India, a Mumbai-based B2B distributor of health ingredients — from amino acids to herbal extracts to vitamins — now going public with a ₹300 Cr ambition.
They’re not manufacturing yet, but they’re already flexing margins, anchoring ₹22 Cr, and hoping to mix whey with wealth.
Let’s lift the lid on the protein jar and see what’s really inside.
2. 🧪 Business Model – WTF Do They Even Do?
Short version: Chemkart is like the Amazon for raw health ingredients – but strictly B2B.
They don’t own brands, they don’t make pills, and they don’t sell to consumers.
What they do:
Import + distribute amino acids, herbal extracts, vitamins, protein powders, and sports supplements
Provide grinding, blending, labeling, and packaging services at their Bhiwandi unit
Serve nutraceutical manufacturers, supplement startups, and pharma companies
Basically: Your favorite gym brand’s raw material came through Chemkart.
